Alteration of lipid metabolism in cells infected with human cytomegalovirus

Virology

Volumn 404, Issue 1, 2010, Pages 71-77

  Sanchez, Veronica ^a   Dong, Jennifer J ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Gene expression; Herpesvirus; Lipid metabolism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CALPAIN; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL ESTERASE; LEPTIN; LIPOPROTEIN; MEMBRANE PROTEIN; NIEMANN PICK DISEASE TYPE C1 LIKE PROTEIN; PROTEIN; STABILIN 1; TRANSCRIPTIONAL REGULATING FACTOR 1; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CELL DIVISION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LIPID COMPOSITION; LIPID METABOLISM; MACROPHAGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION; VIRION; VIRUS ENVELOPE;

ATP-BINDING CASSETTE TRANSPORTERS; CALPAIN; CELLS, CULTURED; CYTOMEGALOVIRUS; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; LIPID METABOLISM; MACROPHAGES; METABOLIC NETWORKS AND PATHWAYS; UP-REGULATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 77953709444     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.026     Document Type: Article

References (31)

1. Abrahamsen L.H., Clay M.J., Lyle J.M., Zink J.M., Fredrikson L.J., DeSiervo A.J., Jerkofsky M.A. The effects of cytomegalovirus infection on polar lipids and neutral lipids in cultured human cells. Intervirology 1996, 39:223-229.
2. Carlquist J.F., Muhlestein J.B., Horne B.D., Hart N.I., Lim T., Habashi J., Anderson J.G., Anderson J.L. Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36. Atherosclerosis 2004, 177(1):53-59.
3. Chen W., Wang N., Tall A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J. Biol. Chem. 2005, 280(32):29277-29281.
4. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., Nabors L.B., Cobbs C.G., Britt W.J. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62(12):3347-3350.
5. Cox B.E., Griffin E.E., Ullery J.C., Jerome W.G. Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. J. Lipid Res. 2007, 48(5):1012-1021.
6. Gerna G., Baldanti F., Revello M.G. Pathogenesis of human cytomegalovirus infection and cellular targets. Hum. Immunol. 2004, 65:381-386.
7. Goll D.E., Thompson V.F., Li H., Wi W., Cong J. The calpain system. Physiol. Rev. 2003, 83(3):731-801.
8. Harkins L., Volk A.L., Samanta M., Mikolaenko I., Britt W.J., Bland K.I., Cobbs C.S. Specific localisation of human cytomegalovirus nucleic acids and proteins in colorectal cancer. Lancet 2002, 360(9345):1557-1563.
9. Ibanez C.E., Schrier R., Ghazal P., Wiley C., Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 1991, 65:6581-6588.
10. Jerome W.G., Cox B.E., Griffin E.E., Ullery J.C. Lysosomal choleterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesterol ester. Microsc. Microanal. 2008, 14:138-149.
11. Lee C.H., Lee G.C., Chan Y.J., Chiou C.J., Ahn J.H., Hayward G.S. Factors affecting human cytomegalovirus gene expression in human monocyte cell lines. Mol. Cells 1999, 9(1):37-44.
12. Machesky N.J., Zhang G., Raghavan B., Zimmerman P., Kelly S.L., Merrill A.H., Waldman W.J., Van Brocklyn J.R., Trgovcich J. Human cytomegalovirus regulates bioactive sphingolipids. J. Biol. Chem. 2008, 283(38):26148-26160.
13. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., Tall A.R. Phosphorylation of a Pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 2003, 278(39):37368-37374.
14. Mujawar Z., Rose H., Morrow M.P., Pushkarsky T., Dubrovsky L., Mukhamedova N., Fu Y., Dart A., Orenstein J.P., Bobryshev Y.V., Bukrinsky M., Sviridov D. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006, 4(11):1970-1982.
15. Munger J., Bennett B.D., Parikh A., Feng X.-J., McArdle J., Rabitz H.A., Shenk T., Rabinowitz J.S. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 2008, 26(10):1179-1186.
16. Neufeld E.B., Stonik J.A., Demosky S.J., Knapper C.L., Combs C.A., Cooney A., Comly M., Dwyer N., Blanchette-Mackie J., Remaley A.T., Santamarina-Fojo S., Brewer H.B. The ABCA1 transporter modulates late endocytic trafficking. J. Biol. Chem. 2004, 279(15):15571-15578.
17. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 2005, 85:1343-1372.
18. Oram J.F., Vaughan A.M. ATP-binding cassette cholesterol transporter and cardiovascular disease. Circ. Res. 2006, 99:1031-1043.
19. Sanchez V., Spector D. Cyclin-dependent kinase activity is required for efficient expression and post-translational modification of human cytomegalovirus proteins and for production of extracellular particles. J. Virol. 2006, 80(12):5886-5896.
20. Sanchez V., Clark C.L., Yen J.Y., Dwarakanath R., Spector D.H. Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication. J. Virol. 2002, 76(6):2973-2989.
21. Sanchez V., McElroy A.K., Spector D.H. Mechanisms governing maintenance of cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus. J. Virol. 2003, 77(24):13124-13224.
22. Sharon-Friling R., Goodhouse J., Colberg-Poley A.M., Shenk T. Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores. Proc. Natl. Acad. Sci. 2006, 103(50):19117-19122.
23. Sinzger C., Plachter B., Grefte A., The T.H., Jahn G. Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 1996, 173:240-245.
24. Soderberg-Naucler C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J. Intern. Med. 2006, 259:219-246.
25. Stagno S. Cytomegalovirus. Infections of Fetus and Newborn 2006, Saunders, Philadelphia PA. J. Remington, J. Klein, C. Baker, C. Wilson (Eds.).
26. Streblow D.N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayahi E., Ruchti F., Mattison K., Altschuler Y., Nelson J.A. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999, 99(5):511-520.
27. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 1994, 68:1597-1604.
28. Temel R.E., Tang W., Ma Y., Rudel L.L., Willingham M.C., Ioannou Y.A., Davies J.P., Nilsson L.-M., Yu L. Hepatic Neimann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 2007, 117(7):1968-1978.
29. Turtinen L.W., Seufzer B.J. Selective permissiveness of TPA differentiated THP-1 myelomonocytic cell cultures. Microb. Pathog. 1994, 16(5):373-378.
30. Zarubica A., Trompier D., Chimini G. ABCA1, from pathology to membrane function. Eur. J. Physiol. 2007, 453:569-579.
31. Zhou Y.F., Guetta E., Yu Z.X., Finkel T., Epstein S.E. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J. Clin. Invest. 1996, 98(9):2129-2138.